MYND - MYnd Analytics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.2300
+0.0900 (+7.89%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.1400
Open1.1996
Bid1.1900 x 900
Ask1.2500 x 900
Day's Range1.1500 - 1.2500
52 Week Range0.6200 - 4.0800
Volume68,794
Avg. Volume152,058
Market Cap10.361M
Beta (3Y Monthly)4.96
PE Ratio (TTM)N/A
EPS (TTM)-1.5460
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.75
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    MYnd Analytics Interview to Air on Bloomberg International on the RedChip Money Report

    MYnd Analytics, Inc. (MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced an interview with its Chairman of the Board, Robin L. Smith, MD, MBA, will air on The RedChip Money Report television program. The interview will air Sunday, April 21, on Bloomberg International, available in 149 million homes across Europe, the Middle East, and Africa. In the exclusive interview, Dr. Smith discusses MYnd Analytics’ recent developments, key industry trends and growth drivers, as well as insight regarding the Company’s acquisition of Emmaus and its FDA-approved sickle cell treatment.

  • GlobeNewswire6 days ago

    MYnd Analytics CEO to Present at the ThinkEquity Conference in New York City

    MYnd Analytics, Inc. (MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced that Patrick Herguth, Chief Executive Officer, is scheduled to present at the ThinkEquity Conference on Thursday, May 2, at 11:00 AM Eastern Time being held at The Mandarin Oriental Hotel in New York City. MYnd Analytics, Inc. (www.myndanalytics.com), with its wholly owned subsidiary Arcadian Telepsychiatry Services LLC, is a technology-enabled telepsychiatry and teletherapy company that provides enhanced access to behavioral health services, improves patient outcomes and helps lower the costs associated with behavioral health issues.

  • PR Newswire16 days ago

    Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

    NEW YORK , April 5, 2019 /PRNewswire/ -- AmpliPhi Biosciences Corporation (APHB) Lifshitz & Miller  announces investigation into possible breach of fiduciary duties in connection with the sale of APHB ...

  • GlobeNewswire18 days ago

    MYnd Analytics to Host Investor Webinar on April 4 to Provide Update on Recent Developments

    MYnd Analytics, Inc. (MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, will host an investor webinar and live Q&A session on Thursday, April 4, at 11:00 a.m. EST. The webinar will feature a presentation by CEO Patrick Herguth and Chairman Robin L. Smith, MD, MBA discussing MYnd Analytics’ recent developments, key industry trends and growth drivers, as well as insight regarding the Company’s acquisition of Emmaus and its FDA-approved sickle cell treatment. MYnd Analytics, Inc. (www.myndanalytics.com), with its wholly owned subsidiary Arcadian Telepsychiatry Services LLC, is a technology-enabled telepsychiatry and teletherapy company that provides enhanced access to behavioral health services, improves patient outcomes and helps lower the costs associated with behavioral health issues.

  • GlobeNewswire24 days ago

    MYnd Analytics Awarded European Patent on Neuromodulation Platform; Predicts Patients Likely to Respond to TMS for Treating Depression

    MYnd Analytics, Inc. (MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced it has received its first notice of patent allowance in Europe on the Company’s neuromodulation platform for predicting patients likely to respond to Transcranial Magnetic Stimulation (TMS). The allowed patent application is entitled “Method for Assessing the Susceptibility of a Human Individual Suffering from a Psychiatric or Neurological Disorder to Neuromodulation Treatment,” and has an anticipated expiration date in 2029.  The patent has as its subject matter the Company’s proprietary process and proprietary outcome data on the use of individualized Quantitative EEG (QEEG) features to predict non-response of individuals to TMS therapy.

  • GlobeNewswirelast month

    CEO of Arcadian Telepsychiatry Services Invited by URAC to Present at the 2019 Telemed Leadership Forum

    MYnd Analytics, Inc. (MYND), a predictive analytics and telehealth company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has been invited to present at the 2019 Telemed Leadership Forum, entitled, “Transforming Healthcare Delivery,” in Washington, DC, on April 3-5, 2019.  The Forum is hosted by the Utilization Review Accreditation Commission (URAC).

  • ACCESSWIRElast month

    These 4 Tech Stocks Are On The Rise On Wednesday (3/13/19)

    CORAL GABLES, FL / ACCESSWIRE / March 13, 2019 / The future of the tech stock market directly related to the ability of companies in the tech industry to combat the growing obstacles facing humanity. In ...

  • GlobeNewswirelast month

    MYnd Analytics Joins Magellan Healthcare Provider Network to Offer Telebehavioral Health Services

    MYnd Analytics, Inc. (MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has joined the Magellan Healthcare behavioral health provider network to offer telepsychiatry, teletherapy and teleEAP services to its members through Arcadian’s provider network.

  • GlobeNewswire2 months ago

    MYnd Analytics and Arcadian Telepsychiatry Services Announce Partnership with IMPACT Solutions to Provide Tele-EAP Services

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced a partnership with IMPACT Solutions, a leading provider of behavior healthcare and Employee Assistance Programs (EAP) with a broad range of clients across the Midwest, as well as nationally. Under the agreement, Arcadian will provide tele-EAP services for IMPACT Solutions’ customers through its provider network.

  • PR Newswire2 months ago

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of MYnd Analytics, Inc. - MYND

    NEW YORK , Feb. 26, 2019 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

  • GlobeNewswire2 months ago

    MYnd Analytics Provides Business Update

    MYnd Analytics, Inc. (MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today provided the following business update and letter to shareholders from the Company’s CEO, Patrick Herguth.  The Company also reported it has filed its quarterly report on Form 10-Q for the period ending December 31, 2018, which is available at: www.sec.gov.

  • GlobeNewswire2 months ago

    U.S. General Services Administration Awards Federal Supply Schedule to MYnd Analytics to Provide Healthcare IT Services to the Federal Government

    MYnd Analytics, Inc. (MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that the U.S. General Services Administration has awarded a five-year Federal Supply Schedule (FSS) contract as a government supplier, effective January 31, 2019 with the opportunity to renew it for 15 more years. Under the contract, MYnd intends to offer Healthcare Information Technology services to federal government departments and agencies related to our Psychiatric EEG Evaluation Registry, including the Department of Defense and the United States Department of Veterans Affairs (VA) facilities nationwide.

  • GlobeNewswire3 months ago

    MYnd Analytics and Emmaus Life Sciences Provide Update to Shareholders Addressing Questions Related to Merger and Spin-off Transaction

    What percentage of MYnd (to be renamed “Emmaus Life Sciences, Inc.” and referred to as “New Emmaus”) will current MYnd Analytics (“MYnd”) shareholders own upon completion of the transaction? MYnd shareholders will own 5.9% of the fully diluted shares of Emmaus post closing.

  • GlobeNewswire3 months ago

    MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction

    Emmaus’ commercial lead product Endari™ (L-glutamine oral powder) is FDA approved to reduce the acute complications of sickle cell disease Endari addresses a $3 billion.

  • MYnd Analytics, Inc. (NASDAQ:MYND): Time For A Financial Health Check
    Simply Wall St.4 months ago

    MYnd Analytics, Inc. (NASDAQ:MYND): Time For A Financial Health Check

    While small-cap stocks, such as MYnd Analytics, Inc. (NASDAQ:MYND) with its market cap of US$7.8m, are popular for their explosive growth, investors should also be aware of their balance sheet Read More...

  • GlobeNewswire4 months ago

    MYnd Analytics Appoints Senior Industry Executive Patrick Herguth as Chief Executive Officer and Board Member; George Carpenter Assumes New Role as Chief Innovation Officer

    MYnd Analytics, Inc. (MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that Patrick Herguth will be joining the team as Chief Executive Officer and has also been appointed to the Board of Directors. George Carpenter will assume the new role of Chief Innovation Officer.

  • GlobeNewswire5 months ago

    MYnd Analytics Awarded Subcontract to Support Suicide Prevention for the U.S. Department of Health and Human Services

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that it has been awarded a subcontract to incorporate its PEER report within a project to develop a suicide prevention toolkit, for the U.S. Department of Health and Human Services (HHS). George Carpenter, CEO of MYnd stated, “We are honored to be a part of this important project, which involves development of a suicide prevention tool kit for HHS. Importantly, we look forward to leveraging our expertise and the extensive data we have compiled through the PEER registry.

  • GlobeNewswire5 months ago

    Investor Expectations to Drive Momentum within Lawson Products, Kingold Jewelry, Liberty Broadband, Mustang Bio, Artesian Resources, and MYnd Analytics — Discovering Underlying Factors of Influence

    NEW YORK, Nov. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire5 months ago

    MYnd Analytics’ PEER Report Featured on CBS New York

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that the Company’s Psychiatric EEG Evaluation Registry (“PEER”) was featured on CBS New York by medical correspondent Dr. Max Gomez. MYnd Analytics, Inc. (www.myndanalytics.com) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients.

  • ACCESSWIRE6 months ago

    3 Healthcare Stocks Using Technology to Drive Growth

    In fact, there are additional sectors that have just begun to gain investor interest with regard to new advancements in technology. The global big data in the healthcare market is gaining interest and this has been due to the introduction of personalized healthcare systems and demand for high-quality healthcare services. With this technology, healthcare providers are adding to their capabilities by analyzing patient behavior towards a particular treatment and diagnostic patterns, in order to provide them with customized and highly cost-effective services.